Dyslipidemia
📧 Sign up to get email alerts when something new happens for Dyslipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-05-07Clinical Trial Update: The Effects of Natural Versus Man-Made Trans Fatty Acids on Lipoprotein Profiles: A Pilot Study [NA]
A completed pilot clinical trial comparing the effects of natural versus man-made trans fatty acids on lipoprotein profiles, sponsored by UC…
-
CLINICAL_TRIALS trial_result · 2008-03-28Clinical Trial Update: Effect of Irvingia Gabonensis (Bush Mango)on Parameters Associated With Metabolic Syndrome [NA]
A completed clinical trial evaluated the effects of Irvingia gabonensis (bush mango) on parameters associated with metabolic syndrome, inclu…
-
CLINICAL_TRIALS trial_result · 2008-03-13Clinical Trial Update: Postprandial Fatty Acids and FABP2 in Type 2 Diabetes Mellitus (DM) [NA]
A completed clinical trial investigating postprandial fatty acids and FABP2 in individuals with Type 2 Diabetes Mellitus (with dyslipidemia)…
-
CLINICAL_TRIALS trial_result · 2008-03-11Clinical Trial Update: Pharmacological Regulation of Fat Transport in Metabolic Syndrome [Phase 4]
Phase 4 clinical trial update on pharmacological regulation of fat transport in metabolic syndrome; the study has completed.
-
CLINICAL_TRIALS trial_result · 2008-02-28Clinical Trial Update: Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy Humans [NA]
Update on a completed clinical trial examining how subchronic dopamine D2 receptor blockade by antipsychotic drugs affects metabolic paramet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-01-31Clinical Trial Update: TTA in Treatment of Diabetes and Dyslipidemia [Phase 2]
Phase 2 trial of TTA for treatment of Type 2 Diabetes Mellitus and Dyslipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-23Clinical Trial Update: Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions [Phase 4]
Phase 4 trial evaluating the effect of irbesartan, ciprofibrate, and their combination on endothelial function in patients with hypertension…
-
CLINICAL_TRIALS research · 2007-12-12Clinical Trial Update: MARIS Study; Mediterranean Approach to Reduce Insulin-Resistance Study [NA]
The MARIS Study (Mediterranean Approach to Reduce Insulin-Resistance) completed; it investigated strategies to reduce insulin resistance in …
-
CLINICAL_TRIALS trial_result · 2007-12-10Clinical Trial Update: A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder. [Phase 3]
A Phase 3 trial comparing torcetrapib/atorvastatin versus ezetimibe/simvastatin in people with a cholesterol disorder was terminated, accord…
-
CLINICAL_TRIALS trial_result · 2007-11-21Clinical Trial Update: A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol. [Phase 3]
Phase 3 trial comparing torcetrapib/atorvastatin versus simvastatin in adults with high cholesterol has been completed.
-
CLINICAL_TRIALS trial_result · 2007-10-10Clinical Trial Update: Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia [Phase 4]
Phase 4 clinical trial update investigating reversal of antipsychotic-induced side effects, including hyperprolactinemia, weight gain, hyper…
-
CLINICAL_TRIALS trial_result · 2007-09-26Clinical Trial Update: Effect of Omega -3 Fatty Acids Supplements and Plant Sterol Enriched Food in Dyslipidemic Adults [Phase 3]
A Phase 3 clinical trial evaluated omega-3 fatty acid supplements and plant sterol-enriched foods for dyslipidemia. The trial status is comp…
-
CLINICAL_TRIALS trial_result · 2007-09-10Clinical Trial Update: The Use of Irvingia Gabonensis (Bush Mango)and Cissus Quadrangularis to Reduce Weight and Blood Lipids [NA]
A completed clinical trial evaluating Irvingia gabonensis (Bush Mango) and Cissus quadrangularis for weight reduction and lipid changes.
-
CLINICAL_TRIALS trial_result · 2007-09-03Clinical Trial Update: Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes [Phase 2, Phase 3]
An update on fenofibrate for dyslipidemia and metformin-controlled diabetes from Phase 2/Phase 3 trials; the study has completed.
-
CLINICAL_TRIALS trial_result · 2007-09-03Clinical Trial Update: Acceptability of a Fixed Combination of Fenofibrate and Metformin [Phase 3]
An update on a Phase 3 trial evaluating the acceptability of a fixed-dose combination of fenofibrate and metformin for dyslipidemia and diso…
-
CLINICAL_TRIALS trial_result · 2007-09-03Clinical Trial Update: A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome [Phase 3]
A Phase 3 clinical trial update on a combination of fenofibrate and ezetimibe in Type IIb dyslipidemic patients with metabolic syndrome feat…
-
CLINICAL_TRIALS trial_result · 2007-09-03Clinical Trial Update: Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia [Phase 3]
This clinical trial update reports the completion of a Phase 3 acceptability study evaluating a fixed-dose combination of fenofibrate 80 mg …
-
CLINICAL_TRIALS trial_result · 2007-07-20Clinical Trial Update: Lifestyle Intervention in Primary Health Care - the Björknäs Study [Phase 3]
Phase 3 Björknäs Study evaluating a lifestyle intervention in primary health care has completed. The study targets hypertension and type 2 d…
-
CLINICAL_TRIALS trial_result · 2007-06-28Clinical Trial Update: ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency [NA]
This trial update notes a completed study (NCT00493506) evaluating ProAlgaZyme algae infusion for immunodeficiency, with HIV infection and H…
-
CLINICAL_TRIALS trial_result · 2007-04-23Clinical Trial Update: Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia
The clinical trial update reports completion of a study evaluating high-sensitivity C-reactive protein as a clinical marker of inflammatory …
-
FDA approval · 2007-03-16FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for pravastatin sodium submitted by Teva Pharmaceuticals USA, Inc. under ANDA 076056. The action rel…
-
CLINICAL_TRIALS trial_result · 2007-02-26Clinical Trial Update: Effect of Abdominal Obesity on Lipoprotein Metabolism [Phase 3]
A Phase 3 trial evaluating the effect of abdominal obesity on lipoprotein metabolism has been completed.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: A Study in People With Abnormal Fat Levels in the Blood [Phase 2]
A Phase 2 clinical trial update for dyslipidemia sponsored by Eli Lilly and Company has completed; the snippet does not include trial result…
-
CLINICAL_TRIALS trial_result · 2007-01-08Clinical Trial Update: Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes
This clinical trial update notes that the Higashi-Saitama trial evaluating pioglitazone for cardiovascular outcomes in patients with type 2 …
-
CLINICAL_TRIALS trial_result · 2006-11-01Clinical Trial Update: Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL [Phase 4]
A Phase 4 trial (COMPELL) sponsored by Kos Pharmaceuticals evaluated the comparative efficacy of Niaspan (niacin extended-release) plus stat…